The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Cardiovascular disease and COVID-19
Open accessAbstract
Background and aims Many patients with coronavirus disease 2019 (COVID-19) have underlying cardiovascular (CV) disease or develop acute cardiac injury during the course of the illness. Adequate understanding of the interplay between COVID-19 and CV disease is required for optimum management of these patients. Methods A literature search was done using PubMed and Google search engines to prepare a narrative review on this topic. Results Respiratory illness is the dominant clinical manifestation of COVID-19; CV involvement occurs much less commonly. Acute cardiac injury, defined as significant elevation of cardiac troponins, is the most commonly reported cardiac abnormality in COVID-19. It occurs in approximately 8–12% of all patients. Direct myocardial injury due to viral involvement of cardiomyocytes and the effect of systemic inflammation appear to be the most common mechanisms responsible for cardiac injury. The information about other CV manifestations in COVID-19 is very limited at present. Nonetheless, it has been consistently shown that the presence of pre-existing CV disease and/or development of acute cardiac injury are associated with significantly worse outcome in these patients. Conclusions Most of the current reports on COVID-19 have only briefly described CV manifestations in these patients. Given the enormous burden posed by this illness and the significant adverse prognostic impact of cardiac involvement, further research is required to understand the incidence, mechanisms, clinical presentation and outcomes of various CV manifestations in COVID-19 patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263 · cited 5×
“Only one Chinese study reported incidence of heart failure in COVID-19 patients [5].”
BackgroundInfluentialWang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State
Arentz, M., Yim, E., Klaff, L., Lokhandwala, S., Riedo, F. X., Chong, M., & Lee, M. (2020) · JAMA · doi:10.1001/jama.2020.4326 · Cited by 2,259
Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
Li, B., Yang, J., Zhao, F., Zhi, L., Wang, X., Liu, L., Bi, Z., & Zhao, Y. (2020) · Clinical Research in Cardiology · doi:10.1007/s00392-020-01626-9 · Cited by 2,057
Ferrario, C. M., Jessup, J., Chappell, M. C., Averill, D. B., Brosnihan, K. B., Tallant, E. A., Diz, D. I., & Gallagher, P. E. (2005) · Circulation · doi:10.1161/circulationaha.104.510461 · Cited by 1,565
Laboratory abnormalities in patients with COVID-2019 infection
Lippi, G., & Plebani, M. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0198 · Cited by 1,020
Tam, C.-C. F., Cheung, K.-S., Lam, S., Wong, A., Yung, A., Sze, M., Lam, Y.-M., Chan, C., Tsang, T.-C., Tsui, M., et al. (2020) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.120.006631 · Cited by 948
SARS‐coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS
Oudit, G. Y., Kassiri, Z., Jiang, C., Liu, P. P., Poutanen, S. M., Penninger, J. M., & Butany, J. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02153.x · Cited by 893
Coronaviruses and the cardiovascular system: acute and long-term implications
Xiong, T.-Y., Redwood, S., Prendergast, B., & Chen, M. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa231 · Cited by 831
Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic
Weiss, C., Carriere, M., Fusco, L., Capua, I., Regla-Nava, J. A., Pasquali, M., Scott, J. A., Vitale, F., Unal, M. A., Mattevi, C., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c03697 · Cited by 601
Association Between Hospitalization for Pneumonia and Subsequent Risk of Cardiovascular Disease
Corrales-Medina, V. F., Alvarez, K. N., Weissfeld, L. A., Angus, D. C., Chirinos, J. A., Chang, C.-C. H., Newman, A., Loehr, L., Folsom, A. R., Elkind, M. S., et al. (2015) · JAMA · doi:10.1001/jama.2014.18229 · Cited by 591
Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection
Wu, Q., Zhou, L., Sun, X., Yan, Z., Hu, C., Wu, J., Xu, L., Li, X., Liu, H., Yin, P., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09536-z · Cited by 439
Chen, D., Li, X., Song, Q., Hu, C., Su, F., Dai, J., Ye, Y., Huang, J., & Zhang, X. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.11122 · Cited by 398
Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19
Bozkurt, B., Kovacs, R., & Harrington, B. (2020) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2020.04.013 · Cited by 355
Metabolic syndrome and COVID-19: An update on the associated comorbidities and proposed therapies
Costa, F. F., Rosário, W. R., Farias, A. C. R., de Souza, R. G., Gondim, R. S. D., & Barroso, W. A. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.06.016 · Cited by 161
Bradycardia in Patients With COVID-19: A Calm Before the Storm?
Amaratunga, E. A. D. T., Corwin, D. S., Moran, L. N., & Snyder, R. H. (2020) · Cureus · doi:10.7759/cureus.8599 · Cited by 91
Wehbe, Z., Hammoud, S. H., Soudani, N., Zaraket, H., EL‐Yazbi, A. F., & Eid, A. H. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00836 · Cited by 73
Cited by
SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development
Wang, M.-Y., Zhao, R., Gao, L.-J., Gao, X.-F., Wang, D.-P., & Cao, J.-M. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.587269 · Cited by 874
Iddir, M., Brito, A., Dingeo, G., Fernandez Del Campo, S. S., Samouda, H., La Frano, M. R., & Bohn, T. (2020) · Nutrients · doi:10.3390/nu12061562 · Cited by 786
Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic
Weiss, C., Carriere, M., Fusco, L., Capua, I., Regla-Nava, J. A., Pasquali, M., Scott, J. A., Vitale, F., Unal, M. A., Mattevi, C., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c03697 · Cited by 601
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021) · International journal of health sciences · doi:10.53730/ijhs.v5n2.2937 · Cited by 489
Myocardial injury and COVID-19: Possible mechanisms
Babapoor-Farrokhran, S., Gill, D., Walker, J., Rasekhi, R. T., Bozorgnia, B., & Amanullah, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117723 · Cited by 481
Metadata
- Authors
- Bansal, M.
- Venue
- Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Publisher
- Elsevier BV
- Published
- 2020-05
- Volume
- 14
- Issue
- 3
- Pages
- 247-250
- ISSN
- 1871-4021 (ISSN-L)
- OpenAlex
- W3012738153
- Cited by
- 999
- References
- 20
- FWCI
- 26.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.